CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 60 enrolled
Drug / intervention
maintenance with sevoflurane +1 moreprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02065635
NCT02065635N/ACompleted

Investigation of Changes in the Levels of Exhaled NO and Eosinophil Blood Count in Patients Undergoing Thyroidectomy by Two Different Methods of General Anesthesia Maintenance

Aretaieion University Hospital·interventional·Posted Feb 19, 2014·Updated Feb 1, 2022

In Brief

A clinical study evaluating maintenance with sevoflurane and maintenance with propofol for Anesthesia and 2 related conditions. Completed, enrolled 60 participants across 1 site.

Detailed Summary

* Nitric oxide (NO) is a free radical in gas state which plays an important role in a variety of processes relevant to respiratory physiology. It represents a means of detecting airway hyperresponsiveness and appears to have a strong correlation with the eosinophilic infiltration of the airway. Patients who suffered bronchospasm or laryngospasm intraoperatively or postoperatively showed higher levels of exhaled NO. * Propofol modifies NO production by stimulating the constitutive synthesis of NO and by inhibiting the inducible production of NO. It seems to exert protective effects on acute lung injury (ALI) in experimental models and it can possibly reduce exhaled NO. There is also evidence that some intravenous anesthetic agents can influence chemotaxis of eosinophils in vitro. * Variation of exhaled NO and eosinophils in surgical patients undergoing anesthesia has not been studied before. Therefore, the aim of this study will be to investigate the differential impact of maintenance of general anesthesia with propofol versus maintenance with sevoflurane on exhaled NO and eosinophil blood count.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesGreece
Collaborators--

Timeline

N/ACompletedFinished
2014201520162017201820192020202120222023202420252026
First PostedFeb 19, 2014
Enrollment StartMay 1, 2014
Primary CompletionApr 1, 2018
TodayJul 2, 2026
Enrollment to primary: 3.9 yearsPosted 12.4 years ago

Interventions

maintenance with sevofluraneprocedure

in patients allocated to the sevoflurane group, general anesthesia will be maintained with sevoflurane

maintenance with propofolprocedure

in patients allocated to the propofol group, general anesthesia will be maintained with propofol